Boston startup Beta Bionics Inc. is headed into a pair of ambitious pivotal trials in 2020: one starting for an autonomous bionic pancreas device with insulin only and another to follow for a bihormonal version that also includes glucagon. These are expected to offer more precise, easy-to-use blood glucose maintenance for type 1 diabetes patients. Read More
SAN FRANCISCO – An implantable blood glucose sensor that is compatible with several insulin pumps as well as various automated software algorithms to form individualized closed-loop systems and can last for up to six months per use seems like a no-brainer. But Senseonics Holdings Inc. is on a very measured path to get there. Read More
